Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin turbinate injection versus placebo in nonallergic rhinitis on intranasal fluticasone
TCTR20261007011Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A, fluticasone, Normal Saline-Benha University in non-allergic rhinitis (NAR), sponsored by Thammasat University. Started Sep 2021; status: completed.
02
Drugs
botulinum toxin type AfluticasoneNormal Saline-Benha University
03
Conditions
non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on TCTR20261007011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261007011.